1990
DOI: 10.1111/j.1540-8175.1990.tb00356.x
|View full text |Cite
|
Sign up to set email alerts
|

Left Ventricular Outflow Tract Obstruction Following Mitral Valve Replacement with Carpentier‐Edwards Prosthesis

Abstract: Left ventricular outflow tract (LVOT) obstruction is a rare complication of mitral valve replacement. In this article, we describe three patients in whom left ventricular outflow tract obstruction occurred following Carpentier‐Edwards porcine mitral valve replacement. All three patients presented with symptomatic mitral regurgitation (angiographic grade 3–4) requiring mitral valve replacement. Preoperatively there was no evidence of hypertrophic obstructive cardiomyopathy by physical exam, echocardiography, or… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

1991
1991
2009
2009

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 12 publications
0
1
0
Order By: Relevance
“…We describe this phenomenon occurring as a result of Mosaic MV but it has also been described in the literature with other bioprosthetic valves such as Edwards Lifesciences, Carpentier-Edwards, Liotta lowprofile porcine bioprosthesis (St Jude Medical), and Pericarbon low-profile pericardial bioprosthesis (Sorin Biomedica). 7,9,10 The principal imaging modality described in the literature for determining persistent LVOT obstruction after MVR, and also its cause, has been transthoracic and transesophageal echocardiography. [6][7][8]11 Intraoperative use of transesophageal echocardiography has expanded its role in evaluation of the LVOT, by permitting immediate visualization after septal myectomy and/or MVR.…”
Section: Discussionmentioning
confidence: 99%
“…We describe this phenomenon occurring as a result of Mosaic MV but it has also been described in the literature with other bioprosthetic valves such as Edwards Lifesciences, Carpentier-Edwards, Liotta lowprofile porcine bioprosthesis (St Jude Medical), and Pericarbon low-profile pericardial bioprosthesis (Sorin Biomedica). 7,9,10 The principal imaging modality described in the literature for determining persistent LVOT obstruction after MVR, and also its cause, has been transthoracic and transesophageal echocardiography. [6][7][8]11 Intraoperative use of transesophageal echocardiography has expanded its role in evaluation of the LVOT, by permitting immediate visualization after septal myectomy and/or MVR.…”
Section: Discussionmentioning
confidence: 99%